Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Account managing device, image processing system, and storage medium
Verifiable service policy implementation for intermediate networking devices
Submersible remote smoke sensor
Battery loading and unloading mechanism
Drive apparatus
Display apparatus, control method thereof, and program
System and method for leveraging independent innovation in entertainment content and graphics hardware
  Randomly Featured Patents
Process for densifying polycrystalline articles
Small hole saw mandrel assembly
Pipeline casing insulator
Loaded line phase shifter
Error correction apparatus
Method and apparatus for new device driver installation by an operating system
Changeable grip
Turbine with circumferential support and stationary pressure release means
Interstitial brain cooling probe and sheath apparatus
Multidirectional audio decoding